Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, PhD, an academic pioneer in the field of Artificial Intelligence in biology. The company was built on the belief that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is building a global research network — using federated learning — connecting data scientists, clinicians, researchers, and pharma on a research platform that keeps the data secure and preserves privacy. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $55M from leading VC funds and is now working with the largest cancer centers and pharmaceutical companies in Europe and in the US.

OWKIN
Senior Management Team

THOMAS CLOZEL, MD
CO-FOUNDER & CEO
GILLES WAINRIB, PhD
CO-FOUNDER & CSO
ISABELLE LAFORGUE
Executive VP, Finance and Operations
MIKHAIL ZASLAVSKIY, PhD
CHIEF RESEARCH OFFICER
ANNA HUYGHUES-DESPOINTES
HEAD OF STRATEGY AND MARKETING
MERIEM SEFTA, PhD
HEAD OF PARTNERSHIPS
MATHIEU GALTIER, PhD
CHIEF PRODUCT OFFICER
MICHAËL PRESSIGOUT
Chief Growth Officer
PIERRE COURTIOL
CHIEF DATA SCIENTIST
CAMILLE MARINI, PhD
Chief Technology Officer
JOCELYN DACHARY
Head of IT Operations & IT Partnerships

OWKIN
Board of Directors

BRUNO STRIGINI, PharmD
Former CEO Novartis Oncology
THOMAS CLOZEL, MD
CO-FOUNDER & CEO
GILLES WAINRIB, PhD
CO-FOUNDER & CSO
NICOLE JUNKERMANN
Founder NJF Holdings
BRUNO RAILLARD
Partner Frst Capital
ALEX PASTEUR
Partner F-Prime Capital
LAURENT HIGUERET, PharmD
Investment Director, Large Venture Fund Bpifrance
JACKY ABITBOL
Partner Cathay Innovation

OWKIN
Advisory Board

JEAN-PHILIPPE VERT, PhD
Senior Staff Research Scientist at Google Brain
OLIVIER ELEMENTO, PhD
Director, Englander Institute for Precision Medicine at Weill Cornell Medical College
ROGER STUPP, MD
Professor of Medicine, Neurology and Neurological Surgery, Northwestern University Feinberg School of Medicine
JOËL BESSE
FEED AND HEAL THE WORLD – BIOTECH AND FOODTECH ENTREPRENEUR AND INVESTOR
FREDRIK NYLANDER
Dynamic Mercenary at 163 Advisors Ltd

OWKIN
Investors

OWKIN
TEAM

Team Metrics

0
People
0
PhDs
3
MDs
0
Publications

Team Backgrounds